You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pancreatic Cancer Resectable

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer Resectable Trial (Acetylsalicylic acid, Placebo)

Not yet recruiting
  • Pancreatic Cancer Resectable
  • Acetylsalicylic acid
  • Placebo
  • (no location specified)
Dec 5, 2022

Pancreatic Adenocarcinoma, Pancreatic Cancer Resectable Trial in Cádiz (Folfirinox and Stereotactic Body Radiotherapy)

Recruiting
  • Pancreatic Adenocarcinoma
  • Pancreatic Cancer Resectable
  • Folfirinox and Stereotactic Body Radiotherapy
  • Cádiz, Spain
    Hospital Puerta del Mar
Aug 5, 2022

Trajectories of Fatigue and Quality of Life in People With Both

Not yet recruiting
  • Pancreatic Cancer Resectable
  • Diabetes Mellitus
    • (no location specified)
    Aug 22, 2023

    Candidates for Neoadjuvant Treatment in Resectable Pancreatic

    Completed
    • Pancreatic Cancer
    • Neoadjuvant
    • Neoadjuvant treatment
    • (no location specified)
    Nov 9, 2023

    Pancreatic Cancer Trial in Aurora (TTI-101)

    Not yet recruiting
    • Pancreatic Cancer
    • Aurora, Colorado
      University of Colorado
    Nov 30, 2023

    Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB Trial in Shanghai (sintilimab,

    Not yet recruiting
    • Pancreatic Cancer, Stage IB
    • +3 more
    • Shanghai, Shanghai, China
      Zhongshan Hospital
    Jan 4, 2023

    Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in

    Not yet recruiting
    • Pancreas Adenocarcinoma
    • +2 more
    • Nab paclitaxel
    • +3 more
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    Apr 19, 2023

    Pancreatic Cancer Trial in Seoul (Preoperative Stereotactic body radiation therapy (SBRT), Pancreatic resection, Adjuvant

    Recruiting
    • Pancreatic Cancer
    • Preoperative Stereotactic body radiation therapy (SBRT), Pancreatic resection, Adjuvant Chemotherapy
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Jan 10, 2023

    ctDNA in Resectable and Borderline Resectable Pancreatic Cancer

    Recruiting
    • Pancreatic Cancer
    • SIGNATERA™ ctDNA testing
    • Fairfax, Virginia
      Inova Schar Cancer Institute
    Oct 26, 2022

    Pancreatic Carcinoma Trial in Nanjing (Toripalimab, Gemcitabine, Nab paclitaxel)

    Not yet recruiting
    • Pancreatic Carcinoma
    • Nanjing, Jiangsu, China
      The Affiliated Nanjing Drum Tower Hospital of Nanjing University
    Oct 6, 2023

    Resectable Pancreatic Cancer Trial in Tianjin (AG Followed by FOLFIRINOX)

    Recruiting
    • Resectable Pancreatic Cancer
    • AG Followed by FOLFIRINOX
    • Tianjin, Tianjin, China
      Rui Liu
    Jan 8, 2023

    Pancreatic Cancer Trial in Houston (Enhanced Usual Care, Tele-supervised resistance exercises)

    Not yet recruiting
    • Pancreatic Cancer
    • Enhanced Usual Care
    • Tele-supervised resistance exercises
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 20, 2023

    Pancreatic Cancer, Surgery, Metastasis Trial (Histamine DiHCl (HDC), Interleukin-2 (IL-2))

    Not yet recruiting
    • Pancreatic Cancer
    • +3 more
    • Histamine Dihydrochloride (HDC)
    • Interleukin-2 (IL-2)
    • (no location specified)
    Mar 31, 2023

    Borderline Resectable Pancreatic Cancer Trial in Verona (Intraoperative radiotherapy)

    Suspended
    • Borderline Resectable Pancreatic Cancer
    • Intraoperative radiotherapy
    • Verona, Italy
      General and Pancreatic Surgery Unit, Pancreas Institute, Univers
    Nov 1, 2022

    Pancreatic Cancer Trial in Saint Louis (Daily Adaptive External Beam Radiation Therapy)

    Recruiting
    • Pancreatic Cancer
    • Daily Adaptive External Beam Radiation Therapy
    • Saint Louis, Missouri
      Washington University, St. Louis
    Mar 7, 2023

    Pancreas Cancer, Pancreas Adenocarcinoma, Lymph Node Metastasis Trial in Denmark, Sweden (PALN resection)

    Recruiting
    • Pancreas Cancer
    • +2 more
    • PALN resection
    • Odense, Denmark
    • +5 more
    Sep 26, 2023

    Pancreas Cancer, Non-Resectable Pancreas Carcinoma Trial in Aalborg (Gemcitabine, Nab paclitaxel)

    Not yet recruiting
    • Pancreas Cancer
    • Non-Resectable Pancreas Carcinoma
    • Aalborg, Denmark
      Department of Oncology, Aalborg University Hospital
    May 1, 2023

    Resected Pancreatic Adenocarcinoma

    Completed
    • Pancreatic Cancer Resectable
    • Multigene panel for next-generation sequencing
    • Shanghai, Shanghai, China
      Ruijin Hospital
    Jul 31, 2022

    Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

    Recruiting
    • Borderline Resectable Pancreatic Adenocarcinoma
    • +5 more
    • Durvalumab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Pancreatic Cancer Trial in Shatin (MSLN CART)

    Not yet recruiting
    • Pancreatic Cancer
    • MSLN CART
    • Shatin, N.t., Hong Kong
      Endoscopy Centre, Prince of Wales Hospital
    Sep 19, 2023

    Pancreatic Cancer, Locally Advanced Trial in Beijing (Later-line therapy)

    Recruiting
    • Pancreatic Cancer
    • Locally Advanced
    • Later-line therapy
    • Beijing, China
      Department of Medical Oncology, Peking Union Medical College Hos
    Apr 10, 2023

    Pancreatic Carcinoma Trial in Nanjing (Tislelizumab, Gemcitabine, Nab paclitaxel)

    Recruiting
    • Pancreatic Carcinoma
    • Nanjing, Jiangsu, China
      The Affiliated Nanjing Drum Tower Hospital of Nanjing University
    Dec 1, 2022

    Pancreatic Cancer, Cancer of the Pancreas, Pancreas Cancer Trial in Saint Louis (CDX-301, CDX-1140, Research blood draw)

    Recruiting
    • Pancreatic Cancer
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 17, 2023

    ctDNA-based Minimal Residual Disease Detection for Resected

    Not yet recruiting
    • Pancreatic Cancer Resectable
    • ctDNA-based MRD detection
    • Shanghai, Shanghai, China
      Ruijin Hospital Affiliated to Shanghai Jiao Tong University Scho
    Jul 29, 2022

    Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma Trial in Netherlands (Leucovorin

    Recruiting
    • Pancreatic Cancer
    • +2 more
    • Leucovorin Calcium
    • +4 more
    • 's-Hertogenbosch, Netherlands
    • +19 more
    Jan 6, 2023